Skip to Main Content

Paper Details

Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
Neuro Oncol
21
2021
-, CNS, CNS NB, CNS embryonal, CNS embryonal tumor, CNS neuroblastoma, CNS tumor, CNS-, CNS-PNET, CNS-primitive neuroectodermal tumors, DNA, DNA methylation arrays, ETMR, FOXR2, HGG, PNET, Patients, embryonal tumors, high-grade glioma, multilayered rosettes, patients, tumors
Author NameAffiliation
Katja von HoffCharite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Christine HaberlerMedical University of Vienna
Christelle DufourGustave Roussy Cancer Center
Christelle DufourINSERM, Paris-Saclay University
Irene SlavcDepartment of Pediatrics and Adolescent Medicine and Comprehensive Center for Pediatrics, Medical University of Vienna
Johannes GojoDepartment of Pediatrics and Adolescent Medicine and Comprehensive Center for Pediatrics, Medical University of Vienna
Nicolas U GerberUniversity Children's Hospital
Maura MassiminoFondazione IRCCS Istituto Nazionale dei Tumori
Maura MassiminoFondazione IRCCS Istituto Nazionale dei Tumori
Ofelia CruzHospital Sant Joan de Deu
Michael A GrotzerUniversity Children's Hospital
Konstantin OkonechnikovHopp Children's Cancer Center (KiTZ)
Konstantin OkonechnikovGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan RutkowskiUniversity Medical Center Hamburg-Eppendorf
Stefan RutkowskiUniversity Medical Center Hamburg-Eppendorf
Ulrich Sch??llerUniversity Medical Center Hamburg-Eppendorf
Ulrich Sch??llerResearch Institute Children's Cancer Center Hamburg
Ulrich Sch??llerInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf
Eugene I HwangCenter for Cancer and Immunology Research and Neuroscience Research, Children's National Medical Center
Eugene I HwangCenter for Cancer and Immunology Research and Neuroscience Research, Children's National Medical Center
Dominik SturmGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Dominik SturmHeidelberg University Hospital
Dominik SturmGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Dominik SturmHeidelberg University Hospital
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHopp Children's Cancer Center (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHopp Children's Cancer Center (KiTZ)
Andreas von DeimlingHeidelberg University Hospital
Andreas von DeimlingClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Elisabeth J RushingInstitute of Neuropathology, University Medical Center Zurich
Marina RyzhovaBurdenko Neurosurgical Institute
Marina RyzhovaBurdenko Neurosurgical Institute
Felice GiangasperoSapienza University of Rome
Felice GiangasperoIRCCS Neuromed
Cynthia HawkinsThe Hospital for Sick Children
Cynthia HawkinsThe Hospital for Sick Children
Dominique Figarella-BrangerAix-Marseille University APHM, CNRS
Charles G EberhartJohns Hopkins University
Charles G EberhartJohns Hopkins University
Peter C BurgerJohns Hopkins University
Andrey KorshunovHeidelberg University Hospital
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Andrey KorshunovHeidelberg University Hospital
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Thomas S JacquesGreat Ormond Street Hospital for Children NHS Foundation Trust
David CapperCharite University Medicine and Berlin Institute of Health
David CapperGerman Cancer Research Center (DKFZ)
  • 1 - 50

Datasets